Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
147
datasets available to search
ShareScore release 0.9.0
Dataset results
147 results for “ADC”
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
ClinicalTrials.gov study NCT07379268. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
ClinicalTrials.gov study NCT06710132. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study of RC48-ADC in Subjects With Advanced Breast Cancer
ClinicalTrials.gov study NCT03052634. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04311034. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2
ClinicalTrials.gov study NCT05601401. IPD Sharing: NO. Countries: 1. Publications: 0.
FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06519370. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter and Real-world Analysis of RC48-ADC in Patients With HER2-positive or HER2-low Expressing, Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT06168227. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
ClinicalTrials.gov study NCT07251868. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer
ClinicalTrials.gov study NCT05016973. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
ClinicalTrials.gov study NCT06311214. IPD Sharing: YES. Countries: 1. Publications: 0.
RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects
ClinicalTrials.gov study NCT05943379. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the
ClinicalTrials.gov study NCT06959108. IPD Sharing: YES. Countries: 0. Publications: 0.
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
ClinicalTrials.gov study NCT06877416. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov study NCT07115485. IPD Sharing: NO. Countries: 1. Publications: 0.
Repeatability and Reproducibility of the ADC Map in Head and Neck Cancer. Prospective Multicenter Study
ClinicalTrials.gov study NCT06749301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
ClinicalTrials.gov study NCT04965519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT07106892. IPD Sharing: NO. Countries: 1. Publications: 0.
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
ClinicalTrials.gov study NCT06303505. IPD Sharing: NO. Countries: 7. Publications: 0.
RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2
ClinicalTrials.gov study NCT05403242. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
ClinicalTrials.gov study NCT03500380. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.